Endocyte's Series B Round

Endocyte raised a round of funding on July 23, 2001.

Endocyte is a biotechnology company developing receptor-targeted therapeutics or "smart drugs" for the treatment of cancer and autoimmune diseases. The Company focuses on certain types of cancer cells…

Articles about Endocyte's Series B Round: